NCT07127289

Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy

A Prospective, Single-Arm, Single-Center Study of Autologous Hematopoietic Stem Cell Infusion for Prolonged Cytopenia After CAR-T Cell Therapy

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Institute of Hematology & Blood Diseases Hospital, China · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective, single-arm, single-center clinical study designed to evaluate the safety of autologous hematopoietic stem cell infusion for the treatment of prolonged cytopenia following CAR-T cell therapy. Approximately 20 patients will be enrolled.

Conditions

• Prolonged Cytopenia Following CAR-T Therapy

Interventions

Type	Name	Description
BIOLOGICAL	Autologous hematopoietic stem cell infusion	Autologous hematopoietic stem cell infusion (0.5-3.0×10\^6/kg)

Timeline

• Start date: 2025-08-01
• Primary completion: 2027-08-01
• Completion: 2028-08-01
• First posted: 2025-08-17
• Last updated: 2025-08-17

Locations

1 site across 1 country: China